|
|||||
|
|
Evaluation of the safety of sodium-glucose co-transporter-2 inhibitors for treating patients with type 1 diabetes |
|
| Authors: | Weihao Wang MD Lina Zhang MD Xiaobei Pei MBBS Qi Pan MD Lixin Guo MD |
| Affiliation: | Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China |
| Abstract: | |
| Keywords: | safety SGLT-2 inhibitors type 1 diabetes |